Ganesh Raghu

  Ganesh Raghu M.D., FACP, FCCP
Professor of Medicine & Laboratory Medicine
Pulmonary and Critical Care Medicine
Director - Interstitial Lung Disease / Sarcoid / Pulmonary Fibrosis Program
Medical Director, Lung Transplant Program


OFFICE ADDRESS
University of Washington Medical Center
1959 N.E. Pacific, Campus Box 356522
Seattle, WA 98195-6522

graghu@u.washington.edu
Academic Office: (206) 543-3166
Fax: (206) 685-8673
Clinic Appointments: (206) 598-4615
Clinic Fax: (206) 598-2105

EDUCATION AND TRAINING
M.D., Mysore Medical College, University of Mysore, Mysore, India, 1973.

Internship, University Hospitals, University of Mysore, Mysore, India, 1974.

Residency in General Medicine and Chest Medicine, Hartlepool General Hospital and Postgraduate Medical Center (University of Newcastle Upon Tyne), Hartlepool, England, 1977.

Residency in Internal Medicine, State University of New York, Buffalo, NY, 1980.

Chief Medical Resident, State University of New York, Buffalo, NY, 1980-1981.

Fellowship in Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, 1983.

Fellowship in Lung Cell Biology, University of Washington, Seattle, WA, 1985.

CURRENT RESEARCH INTERESTS
Clinical:
Diagnosis and treatment of interstitial lung diseases (ILD)
Significance of gastroesophagial reflux in the management of ILD and IPF
Role of HRCT and lung biopsy in idiopathic pulmonary fibrosis (IPF)
Treatment of IPF in the context of clinical trials
Genetic predisposition of idiopathic pulmonary fibrosis and familial IPF
Management of sarcoidosis
Outcome measures in IPF
Lung transplantation: Treatment of rejection, infection

Basic Science: Pathogenesis of pulmonary fibrosis:

Human lung fibroblast heterogeneity
Genetic susceptibility of pulmonary fibrosis.

REPRESENTATIVE PUBLICATIONS
Raghu G, Brown K, Bradford W, Starko K, Noble P, Schwartz D, King T.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.  NEJM. 350:125-133, 2004

Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, Sato A, Judoh S, Raghu G. Double blind, placebo-controlled trial of perfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171(9):1040-47.

Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE 2nd, Pellegrini CA. High prevalence of abnormal acid gastroesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006. Jan;27(1):136-42.

Raghu G, Weycker D, Bradford W, Oster G.  Incidence and prevalence of idiopathic pulmonary fibrosis.  AJRCCM 2006;174:810-6.

Flaherty K, Andrei AC, King TE Jr, Raghu G, Colby TV, et al.  Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?  AJRCCM 2007;175:1054-1060.

Tsakiri KD, Cronkhite JT, Kaun PJ, Xing C, Raghu G, Weissler JC, Rosenblatt RL, Shay JW, Garcia CK. Adult-onset pumonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007;104:7552-7557.

Raghu G. Idioopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches. (editorial) ERJ, Sep 2006;28:463-465.

Pulmonary Medicine Home | Faculty Home | UW Home | UWMC | DOM Home | HMC | FHCRC | Academic Health Links | Search SOM

Please honor our copyrights and disclaimer.
Copyright
©1998 University of Washington. All rights reserved.
Comments to Donna Schier, dschier@u.washington.edu
Last Updated: August 14, 2007